Management of acute meningitis
ABSTRACT
Acute meningitis remains a devastating disease. Clinicians need a low threshold for suspecting meningitis, to undertake appropriate investigations and provide treatment in a timely manner, to minimise the risk of poor outcome in bacterial disease, while limiting unnecessary treatment in viral meningitis.
Key points
Viral meningitis is the most common form of meningitis in the UK, but bacterial meningitis continues to be important, with a high mortality
Clinical features are poor discriminators for meningitis, so urgent investigations, starting with lumbar puncture, are key
Most patients do not need brain imaging before lumbar puncture. Patients exhibiting clinical features of brain shift warrant urgent CT. Otherwise, imaging can cause delays in commencing antibiotics, which can lead to increased mortality
Aim to take 10 mL of CSF during LP. Larger volumes are especially useful to diagnose tuberculous meningitis, and enable additional aliquots to be available for further diagnostic testing
Prompt testing of CSF and blood by PCR can hasten pathogen diagnosis and improve patient management
Definitions
Meningitis is inflammation of the meninges covering the brain. It is a pathological definition. The cerebrospinal fluid (CSF) typically exhibits an elevated number of leucocytes (or a pleocytosis). In adults, >5 leucocytes/μL is defined as elevated. Bacterial or viral meningitis is confirmed by the detection of a pathogen in the CSF. Bacterial meningitis may also be suggested by symptoms of meningism and appropriate bacteria in the blood.1
Causes
The most common causes of meningitis in immunocompetent adults in the UK are viruses and bacteria. Viruses account for up to half of cases. Enterovirus is the commonest, with herpes simplex and varicella zoster the next most frequent. Streptococcus pneumoniae and Neisseria meningitidis are the commonest bacteria, together accounting for approximately one-quarter of cases.
Other causes such as Haemophilus influenzae, Listeria monocytogenes, Mycobacterium tuberculosis and fungi (typically cryptococci) are less frequently detected, together representing <10% of cases. Currently, many adults with meningitis have no pathogen detected.2–5
Although this article refers to Listeria and tuberculous meningitis, it purposely focuses on the more common causes, ie viral and bacterial meningitis.
Clinical features
Clinical features alone cannot confirm the diagnosis of meningitis. A lumber puncture (LP) is essential to confirm the diagnosis of meningitis and establish the cause.
In one study, 95% of bacterial meningitis patients had at least two symptoms of headache, neck stiffness, fever and altered consciousness. The latter three features were present together in only 44% of cases. Neurological deficits are found in around one-third of patients.6 Similar findings are reported by other studies.7–9
A rash in suspected meningitis makes N meningitidis more likely. However, 37% of meningococcal meningitis patients have no rash.8 Varicella and enterovirus can also be associated with a rash.
Risk factors for Listeria meningitis include overt or relative immune compromise, the latter including chronic illness, diabetes, alcohol dependency, malignancy or old age. Listeria meningitis is rarely seen in immunocompetent adults under 60 years of age.1,10
Travel history, symptoms of otitis media / sinusitis, contact with another person with meningitis, sepsis or tuberculosis are other useful diagnostic clues.
Investigations
Lumbar puncture
Lumbar puncture is the key investigation. It enables rapid confirmation of meningitis and type of infecting organism. Diagnostic yield of LP can be diminished by collecting small CSF volumes. At least 10 mL can be safely removed.11,12
Cerebrospinal fluid cell count
Cerebrospinal fluid remains one of the most rapidly informative tests. Pleocytosis indicates meningeal inflammation, of which infection is the most common cause. Van de Beek and colleagues reported that >90% of adults with bacterial meningitis had a CSF leukocyte count >100 cells/μL.6 Absence of pleocytosis makes meningitis much less likely, but does not completely rule it out. Approximately 1–2% of patients with bacterial meningitis will have a normal CSF leukocyte count. Positive pathogen detection and an absence of pleocytosis more frequently occurs among children, the immunocompromised, those pretreated with antibiotics or with mycobacteria tuberculosis infection.13
Cerebrospinal fluid leukocyte differential
Cerebrospinal fluid leukocyte differential can help predict which type of pathogen is causing infection. Lymphocyte predominance suggests viral, while neutrophil predominance suggests bacterial infection. There are several exceptions to this general guide, including CSF neutrophil predominance observed in association with tuberculous meningitis (Table 1).
Cerebrospinal fluid biochemistry
Cerebrospinal fluid glucose is normally approximately two-thirds the blood (plasma) concentration. It is often lower in bacterial and tuberculous meningitis. As CSF glucose is influenced by the plasma glucose, it is essential to measure blood glucose at LP, to obtain an accurate CSF:blood glucose ratio. A CSF:blood glucose ratio <0.36 is an accurate (93%) marker for distinguishing bacterial from viral meningitis.1
Cerebrospinal fluid protein is normally <0.4 g/L. Elevated protein suggests inflammation. A CSF protein < 0.6 g/L largely rules out bacterial infection.1
Cerebrospinal fluid parameters
Cerebrospinal fluid parameters have been combined into tools to help diagnose bacterial meningitis. One prediction rule accurately distinguished bacterial from viral meningitis in two adult patient populations using retrospective data (area under the curve 0.97).14,15 Clinical prediction tools (using CSF, laboratory and clinical parameters) have also exhibited high accuracy when tested retrospectively in large child populations.16 No tools have been validated prospectively in adults in the UK.
Pathogen detection
Cerebrospinal fluid microscopy with Gram stain
Cerebrospinal fluid microscopy with Gram stain (or an acid fast stain for M tuberculosis) can rapidly detect bacteria. It has a sensitivity between 50% and 99%.6 Detection, particularly for M tuberculosis, is enhanced by collection of >10 mL of CSF and subsequent cytospin.11
Cerebrospinal fluid culture
Cerebrospinal fluid culture is historically regarded as the ‘gold standard’ for the diagnosis of bacterial meningitis. It is diagnostic in 70–85% of cases prior to antibiotic exposure. Sensitivity decreases by 20% following antibiotic pretreatment. Cerebrospinal fluid sterilization can occur within 2–4 hours of antibiotic administration for meningococci and pneumococci respectively.15 Lumbar puncture should be performed as soon as possible to maximise pathogen detection.
Cerebrospinal fluid polymerase chain reaction
Cerebrospinal fluid polymerase chain reaction (PCR), using pathogen specific nucleic acid sequences, can detect both bacteria and viruses with high sensitivity. Polymerase chain reaction is the ‘gold standard’ for diagnosis of viral meningitis. Polymerase chain reaction is increasingly relied upon in bacterial meningitis. It has far greater sensitivity than culture in invasive meningococcal disease.17 Cerebrospinal fluid PCR is particularly valuable in patients who receive antibiotics before LP. Polymerase chain reaction for 16S ribosomal RNA (present in almost all bacteria) enables a broad screen for bacteria, but has lower sensitivity than pathogen specific PCR.1,15
Blood tests
Blood cultures should always be taken on admission and are helpful when antibiotics are started before LP. Blood cultures are positive in 50–80% of bacterial meningitis cases.15
Blood PCR is increasingly important, especially as PCR detects bacteria several days after antibiotic initiation.17 Blood PCR substantially increases the confirmation in meningococcal disease.18
Despite these tests, many patients will not have a cause identified for their meningitis.
Blood biomarkers, such as procalcitonin and C-reactive protein, can help distinguish bacterial from viral meningitis in adults and can be used to help guide treatment if no aetiology is found.19,20 Host biomarkers for detecting bacterial meningitis are being actively investigated by our Liverpool group and others. To date, there is insufficient evidence to recommend their routine use in the NHS.1
Swabs
Throat, nasopharyngeal, and stool swabs are useful for detecting enteroviruses if the CSF PCR is negative.
Brain imaging
Brain imaging is neither obligatory in the management of meningitis, nor a prerequisite to LP. Performing neuroimaging before LP is associated with delays in commencing antibiotics, which in turn can lead to an increase in mortality.12,21 An urgent CT scan should be performed if there are clinical signs of brain shift. Clinical features indicative of a brain shift include focal neurological signs and reduced Glasgow Coma Score (GCS) (Box 1). The 2016 UK meningitis guidelines recommend an LP be performed without prior neuroimaging if the GCS is >12.1 Patients with a GCS ≤12 should be considered for critical care, intubation assessment and neuroimaging. Imaging, particularly when contrast is used, may exhibit meningeal enhancement in meningitis. When brain shift is identified liaison with critical care and neurosurgical teams are essential.
A summary of investigations is presented in Fig 1.
Treatment
If a patient exhibits signs of airway, breathing or circulatory difficulties (eg in coexisting sepsis), management should initially focus on stabilisation of these systems.
All patients should be reviewed by a senior clinician. The Royal College of Physicians recommends consultant review for all acute medical patients within 14 hours of admission. Urgency of review should be assessed using the National Early Warning Score. The GCS should be recorded for its prognostic value, and to enable changes to be monitored. Presence of a rash and use of preadmission antibiotics should also be recorded.
If the patient presents with sepsis, they should be managed according to the sepsis guidelines.22 If the infective focus of sepsis is meningitis, then the antibiotic treatment should follow the guidelines for meningitis.1 For example, piperacillin/tazobactam is not recommended for use in sepsis secondary to meningitis, because of its poor penetration of the blood brain barrier. A recent large open-label trial showed no benefit of prehospital antibiotics in sepsis.23 Previous trials for meningitis have also been inconclusive.1 Consequently, the benefit of prehospital antibiotics for suspected meningitis is unclear. Management of other aspects of sepsis, eg circulation, should follow the sepsis guidelines.22
Treatment for bacterial meningitis is antibiotics, with or without steroids. The choice of antibiotics is a three stage process: an initial empirical decision based on clinical suspicion, review following microscopy results, and review again when culture or PCR results are available (Fig 2).
In suspected bacterial meningitis, dexamethasone should be started either shortly before or simultaneously with antibiotics at 10 mg intravenously (IV) 6-hourly. Up until 12 hours after antibiotic initiation, dexamethasone can still be started, but the impact of this on mortality has not been studied. If pneumococcal meningitis is probable, dexamethasone should continue for 4 days. In suspected tuberculous meningitis, dexamethasone provision should follow the recommended guidelines.11 Once another cause of meningitis is probable, dexamethasone should be stopped.
There is no specific treatment for viral meningitis. Treatment with aciclovir has only been of proven benefit in herpes encephalitis, not meningitis. Only if the patient has encephalitic features, such as impairment of consciousness, focal neurological signs, inflammation of brain parenchyma in the region of the temporal lobe on cranial imaging, should aciclovir be considered.
Prognosis
Mortality occurs almost exclusively in bacterial meningitis. Up to 57% in meningococcal sepsis, 30% of pneumococcal and 7% of meningococcal meningitis without sepsis cases die.1,6
Morbidity is common in bacterial meningitis. Van De Beek's study reported focal neurological deficits in 50% of cases, the commonest being hearing impairment (14%), and 14% of cases exhibited moderate to severe disability at discharge.6
Few studies have examined outcome in viral meningitis. One recent study, reported one-third of adult varicella meningitis patients (3/9) suffered sequelae.24 In our experience, viral meningitis patients can suffer cognitive and psychological sequelae. Headaches occur in one-third of patients. Where there is concern, patients should access neuropsychological services, which can help detect subtle impairments and may facilitate functional recovery. Organisations such as the Meningitis Research Foundation (www.meningitis.org) or Meningitis Now (www.meningitisnow.org), can also provide helpful patient information and advocacy.
Conclusion
Many meningitis patients in the UK who have a CSF pleocytosis never have a pathogen identified. Clinicians need to remain vigilant and treat suspected bacterial meningitis promptly. However, with viruses being the most common cause of meningitis, rapid diagnosis via PCR can limit unnecessary antibiotic treatment and expedite hospital discharge.
- © Royal College of Physicians 2018. All rights reserved.
References
- ↵
- ↵
- ↵
- ↵
- ↵
- Turtle L
- ↵
- ↵
- ↵
- Attia J
- ↵
- ↵
- Gillespie IA
- ↵
- ↵
- Moxon CA
- ↵
- ↵
- ↵
- ↵
- ↵
- ↵
- Newcombe J
- ↵
- Morales Casado MI
- ↵
- ↵
- ↵
- ↵
- Alam N
- ↵
Article Tools
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.